Health products that meet regulatory standards at the point of approval can still reach patients substandard, falsified, or entirely unfit for use. This first webinar in the series of 4, establishes the evidence base, drawing on published surveillance data, practitioner experience from across Africa, and real-world cases including the 2022 Gambia tragedy — to map where and how product quality fails throughout the health supply chain. From manufacturing origin to last-mile delivery, the session identifies the specific stages, actors, and system gaps that allow poor-quality products to circulate undetected. It sets the analytical foundation for the three sessions that follow.
This webinar initiative is a result of a collaborative planning process involving SAPICS, Bee Skilled, CMCOMMS, the Ecumenical Pharmaceutical Network (EPN), and the International Association of Public Health Logisticians (IAPHL). The shared diagnosis across all partners is that the field needs not just awareness, but structured, evidence-based professional dialogue that connects global regulatory standards to on-the-ground practice, that produces tangible, transferable learning for the supply chain workforce.
Summary
Across Africa, medicines that are approved, procured, and dispatched can still reach patients substandard, falsified, or entirely ineffective. This webinar opens the four-part series by establishing the evidence base: what poor-quality medical products actually are, the scale of the problem across the continent, which medicines are most affected, and where in the supply chain quality most commonly fails. Drawing on published surveillance data and a panel of practitioners from East, West, and Southern Africa, the session examines the regulatory, supply chain, and market-level root causes — and the patient and economic consequences when those failures go undetected and unaddressed.